Evidence map›Paper›PMID 35157181›Full record

ArticleNeurogenetics2022

Experiences in the molecular genetic and histopathological evaluation of calpainopathies.

Berk Ozyilmaz, Ozgur Kirbiyik, Taha R Ozdemir, Ozge Kaya Ozer, Yasar B Kutbay, Kadri M Erdogan, Merve Saka Guvenc, Şener Arıkan, Tuba Sozen Turk, Murat Yıldırım Kale and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. RecurrentInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Berk OzyilmazGenetic Diagnosis Center, Tepecik Training and Research Hospital, University of Health Sciences, Bornova Building, Sanayi Caddesi No 7, Bornova, Izmir, Turkey. drberk@gmail.com.ORCID 0000-0003-2654-3698
Ozgur KirbiyikGenetic Diagnosis Center, Tepecik Training and Research Hospital, University of Health Sciences, Bornova Building, Sanayi Caddesi No 7, Bornova, Izmir, Turkey.
Taha R OzdemirGenetic Diagnosis Center, Tepecik Training and Research Hospital, University of Health Sciences, Bornova Building, Sanayi Caddesi No 7, Bornova, Izmir, Turkey.
Ozge Kaya OzerGenetic Diagnosis Center, Tepecik Training and Research Hospital, University of Health Sciences, Bornova Building, Sanayi Caddesi No 7, Bornova, Izmir, Turkey.
Yasar B KutbayGenetic Diagnosis Center, Tepecik Training and Research Hospital, University of Health Sciences, Bornova Building, Sanayi Caddesi No 7, Bornova, Izmir, Turkey.
Kadri M ErdoganGenetic Diagnosis Center, Tepecik Training and Research Hospital, University of Health Sciences, Bornova Building, Sanayi Caddesi No 7, Bornova, Izmir, Turkey.
Merve Saka GuvencGenetic Diagnosis Center, Tepecik Training and Research Hospital, University of Health Sciences, Bornova Building, Sanayi Caddesi No 7, Bornova, Izmir, Turkey.
Şener ArıkanGenetic Diagnosis Center, Tepecik Training and Research Hospital, University of Health Sciences, Bornova Building, Sanayi Caddesi No 7, Bornova, Izmir, Turkey.
Tuba Sozen TurkGenetic Diagnosis Center, Tepecik Training and Research Hospital, University of Health Sciences, Bornova Building, Sanayi Caddesi No 7, Bornova, Izmir, Turkey.
Murat Yıldırım KaleDepartment of Neurology, Tepecik Training and Research Hospital, University of Health Sciences, Izmir, Turkey.
Irem Fatma UludagDepartment of Neurology, Tepecik Training and Research Hospital, University of Health Sciences, Izmir, Turkey.
Figen BaydanDepartment of Pediatrics, Division of Pediatric Neurology, Tepecik Training and Research Hospital, University of Health Sciences, Izmir, Turkey.
Filiz SertpoyrazDepartment of Physical Ther. and Rehab, Bakircay University Cigli Training and Research Hospital, Izmir, Turkey.
Pinar GencpinarFaculty of Medicine, Department of Pediatrics, Division of Pediatric Neurology, Izmir Katip Celebi University, Izmir, Turkey.
Gulden DinizSchool of Medicine, Department of Pathology, İzmir Demokrasi University, Izmir, Turkey.
Sağlık Bilimleri Üniversitesi · TRIzmir University · TRBakırçay ÜniversitesiEge University · TRIzmir Kâtip Çelebi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calpainopathy is mainly characterized by symmetric and progressive weakness of proximal muscles. Several reports showed that the most common LGMD subtype is LGMDR1 or calpainopathy, which had previously been defined as LGMD2A. Until now, more than 500 likely pathogenic/pathogenic variants in the CAPN3 gene have been reported. However, a clear genotype-phenotype association had not yet been established and this causes major difficulties in predicting the prognosis in asymptomatic patients and in providing genetic counseling for prenatal diagnosis. In this report, we aimed to add new data to the literature by evaluating 37 patients with likely pathogenic/pathogenic variants for the detected variants' nature, patients' phenotypes, and histopathological features. As a result, the general clinical presentation of the 23 different variants was presented, the high frequency of NM_000070.3:c.550delA mutation in Exon 4 was discussed, and some novel genotype-phenotype associations were suggested. We have underlined that calpainopathy can be misdiagnosed with inflammatory myopathies histopathologically. We have also emphasized that, in young or adult patients with mild to moderate proximal muscle weakness and elevated CK levels, calpainopathy should be the first suspected diagnosis.

Indexed as

CalpainMuscular Dystrophies, Limb-GirdleHumansMolecular BiologyMuscle ProteinsMutationCalpainMuscle ProteinsCalpainopathyCAPN3HistopathologyLGMDNGS

Identifiers

PMID35157181
OpenAlexW4213039472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.